CD8A and colorectal carcinoma: In addition, ENTPD2 in CRC-derived EVs facilitates the conversion of ATP to adenosine, thus inhibiting CD8 + T cell cytotoxic activity and subsequently reshaping an immunosuppressive TME [114].